Inhibition of mTOR prevents glucotoxicity-mediated increase of SA-beta-gal, p16INK4a, and insulin hypersecretion, without restoring electrical features of mouse pancreatic islets

Biogerontology. 2024 Oct;25(5):819-836. doi: 10.1007/s10522-024-10107-9. Epub 2024 May 15.

Abstract

An over-activation of the mechanistic target of rapamycin (mTOR) pathway promotes senescence and age-related diseases like type 2 diabetes. Besides, the regenerative potential of pancreatic islets deteriorates with aging. Nevertheless, the role of mTOR on senescence promoted by metabolic stress in islet cells as well as its relevance for electrophysiological aspects is not yet known. Here, we investigated whether parameters suggested to be indicative for senescence are induced in vitro in mouse islet cells by glucotoxicity and if mTOR inhibition plays a protective role against this. Islet cells exhibit a significant increase (~ 76%) in senescence-associated beta-galactosidase (SA-beta-gal) activity after exposure to glucotoxicity for 72 h. Glucotoxicity does not markedly influence p16INK4a protein within 72 h, but p16INK4a levels increase significantly after a 7-days incubation period. mTOR inhibition with a low rapamycin concentration (1 nM) entirely prevents the glucotoxicity-mediated increase of SA-beta-gal and p16INK4a. At the functional level, reactive oxygen species, calcium homeostasis, and electrical activity are disturbed by glucotoxicity, and rapamycin fails to prevent this. In contrast, rapamycin significantly attenuates the insulin hypersecretion promoted by glucotoxicity by modifying the mRNA levels of Vamp2 and Snap25 genes, related to insulin exocytosis. Our data indicate an influence of glucotoxicity on pancreatic islet-cell senescence and a reduction of the senescence markers by mTOR inhibition, which is relevant to preserve the regenerative potential of the islets. Decreasing the influence of mTOR on islet cells exposed to glucotoxicity attenuates insulin hypersecretion, but is not sufficient to prevent electrophysiological disturbances, indicating the involvement of mTOR-independent mechanisms.

Keywords: Glucose-stimulated insulin secretion; Hyperglycemia; MIN6 cells; Microelectrode arrays; Oxidative stress; Pancreatic beta-cells; Senescence; Sirolimus.

MeSH terms

  • Animals
  • Cells, Cultured
  • Cellular Senescence* / drug effects
  • Cyclin-Dependent Kinase Inhibitor p16* / genetics
  • Cyclin-Dependent Kinase Inhibitor p16* / metabolism
  • Glucose / metabolism
  • Insulin / metabolism
  • Insulin Secretion / drug effects
  • Islets of Langerhans* / drug effects
  • Islets of Langerhans* / metabolism
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Reactive Oxygen Species / metabolism
  • Sirolimus / pharmacology
  • TOR Serine-Threonine Kinases* / metabolism
  • beta-Galactosidase / metabolism

Substances

  • TOR Serine-Threonine Kinases
  • Cyclin-Dependent Kinase Inhibitor p16
  • mTOR protein, mouse
  • Insulin
  • Sirolimus
  • beta-Galactosidase
  • Glucose
  • Reactive Oxygen Species

Grants and funding